Round three of IRA negotiations is expected to be ‘manageable’ for pharmanews2026-01-28T21:19:03+00:00January 28th, 2026|Endpoints News|
FDA asks court to pause Louisiana’s abortion pill fightnews2026-01-28T19:18:46+00:00January 28th, 2026|Endpoints News|
Teva CEO says it has successfully transitioned into a biopharma companynews2026-01-28T17:18:00+00:00January 28th, 2026|Endpoints News|
HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launchnews2026-01-28T15:26:09+00:00January 28th, 2026|Endpoints News|
Hengrui blazes trail as Chinese drugmakers aspire to go multinationalnews2026-01-28T15:00:06+00:00January 28th, 2026|Endpoints News|
Updated: CMS picks Lilly’s Trulicity, Gilead’s Biktarvy for third round of Medicare negotiationsnews2026-01-27T22:26:48+00:00January 27th, 2026|Endpoints News|
Hospitals could earn more for buying US-made drugs, CMS proposesnews2026-01-27T20:05:47+00:00January 27th, 2026|Endpoints News|
Cardiff execs depart as company drops mixed Phase 2 datanews2026-01-27T18:22:21+00:00January 27th, 2026|Endpoints News|
IRA drug pricing petitions pile up at the Supreme Court news2026-01-26T20:21:13+00:00January 26th, 2026|Endpoints News|
Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump schemenews2026-01-26T18:32:33+00:00January 26th, 2026|Endpoints News|
